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The exogenous siRNA pathway is important in restricting arbovirus infection in mosquitoes. Less
is known about the role of the PIWI-interacting RNA pathway, or piRNA pathway, in antiviral
responses. Viral piRNA-like molecules have recently been described following infection of
mosquitoes and derived cell lines with several arboviruses. The piRNA pathway has thus been
suggested to function as an additional small RNA-mediated antiviral response to the known
infection-induced siRNA response. Here we show that piRNA-like molecules are produced
following infection with the naturally mosquito-borne Semliki Forest virus in mosquito cell lines.
We show that knockdown of piRNA pathway proteins enhances the replication of this arbovirus
and defines the contribution of piRNA pathway effectors, thus characterizing the antiviral
properties of the piRNA pathway. In conclusion, arbovirus infection can trigger the piRNA pathway
in mosquito cells, and knockdown of piRNA proteins enhances virus production.
INTRODUCTION
Arboviruses are unique in that they must naturally replicate
in both their invertebrate vector and vertebrate host and
are therefore subjected to the selective pressure of very
different antiviral responses. One of the major antiviral
responses in invertebrates is the RNA silencing pathway or
RNA interference (RNAi). It has been shown that the RNAi
pathway, in particular the exogenous small interfering
(si)RNA pathway, is able to inhibit and restrict arbovirus
infections in whole mosquitoes or mosquito cells (Blair,
2011; Donald et al., 2012). The exogenous RNAi pathway is
induced by virus-derived dsRNA that is recognized by a
Dicer protein, Dcr-2, and is processed into 21 bp-long
virus-derived siRNAs, also called viRNAs. After viRNAs are
incorporated and unwound in the RNA-induced silencing
complex (RISC) that harbours Argonaute 2 (Ago 2) as a
catalytic domain, one strand of the viRNA is retained and
used as a guide to find complementary viral RNA, which is
then degraded. Until recently, it was believed that the anti-
viral response in invertebrates is only attributed to the
exogenous siRNA pathway. Recently, however, the PIWI-
interacting RNA (piRNA) pathway has also been suggested
to display antiviral activity. piRNA molecules differ from
siRNAs in several aspects; they are produced by a Dicer-
independent pathway; have a broader size range of
25229 nt; are associated with proteins of the PIWI clade
and have a so-called ‘ping-pong’ signature due to their
production pathway, which is represented by a bias for U at
position 1 in antisense piRNAs and A at position 10 in
sense piRNAs (Saito & Siomi, 2010; Senti & Brennecke,
2010; Siomi et al., 2010, 2011; van Rij & Berezikov, 2009).
In Drosophila melanogaster, it has been shown that PIWI
proteins are mainly expressed in germline cells and are
thought to protect the germline from transposable
elements by targeting the transcribed RNA of active
transposons. However, PIWI proteins have also been
detected in somatic cells (Brennecke et al., 2007).
Although their induction pathway is still not completely
understood, two mechanisms have been proposed to
describe piRNA biogenesis. Primary piRNA molecules are
3Present address: Dalhousie University, Department of Microbiology &
Immunology/Paediatrics, 5850 College Street, Halifax B3H 1X5,
Canada.
Two supplementary figures and one table are available with the online
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antisense to the genomic regions of transposons and derive
from long precursor ssRNA that targets transposon-derived
sense RNA. Upon cleavage, they give rise to secondary
piRNA molecules that are mostly sense with an A10 bias.
Secondary piRNAs are incorporated into Argonaute 3 (Ago
3) protein, which uses these piRNAs to find complement-
ary antisense RNA, which again results in the production of
primary-type piRNAs. This so-called ping-pong mech-
anism results in the generation of anti-sense primary
piRNA molecules with a U1 bias. Primary piRNA
molecules have mostly been found to form complexes
with Aubergine (Aub) and PIWI proteins (Saito & Siomi,
2010; Senti & Brennecke, 2010; Siomi et al., 2010, 2011; van
Rij & Berezikov, 2009).
The detection of virus-specific piRNA molecules in
drosophila ovary somatic sheet (OSS) cells was the first
report suggesting that the piRNA pathway targeted viruses
in insects (Wu et al., 2010). More recently, virus-specific
piRNA molecules have been reported in aedine mosquitoes
for chikungunya virus (CHIKV) (Togaviridae, Alphavirus)
(Aedes albopictus and Ae. aegypti) and dengue virus
(DENV) (Flaviviridae, Flavivirus) (Ae. aegypti), and their
derived cell lines can become infected with Sindbis virus
(SINV) (Togaviridae, Alphavirus), La Crosse virus (LACV)
(Bunyaviridae, Orthobunyavirus), Rift Valley fever virus
(RVFV) (Bunyaviridae, Phlebovirus) and Schmallenberg
virus (SBV) (Bunyaviridae, Orthobunyavirus) (Hess et al.,
2011; Le´ger et al., 2013; Morazzani et al., 2012; Schnettler
et al., 2013; Vodovar et al., 2012). It is not known whether
these virus-specific piRNA molecules actually mediate any
antiviral activities or which proteins of the piRNA pathway
are important for this response. The PIWI protein clade
shows an expansion in aedine mosquitoes compared
to drosophila, which is consistent with a role besides
transposon targeting. Ae. aegypti encode seven piRNA
proteins (piRNA 1, AAEL008076; piRNA 2, AAEL008098;
piRNA 3, AAEL013692; piRNA 4, AAEL007698; piRNA 5,
AAEL013233; piRNA 6, AAEL013227; piRNA 7, AAEL006287)
and one Ago 3 protein (AAEL007823), compared to D.
melanogaster, which only encodes one of each of piRNA, Ago 3
and Aub (Campbell et al., 2008a).
Although expression of some of the PIWI proteins has been
recently reported in Ae. aegypti-derived Aag2 cell lines
(Vodovar et al., 2012) and in the head and thorax of Ae.
albopictus (Morazzani et al., 2012), nothing is known about
their involvement in antiviral activity. If the piRNA
pathway acts as an antiviral response, then it would be
expected that silencing proteins involved would have a
positive effect on arbovirus replication as observed for the
Ago 2 protein, which is known to be involved in the
siRNA-based antiviral RNAi response (Campbell et al.,
2008b; Sa´nchez-Vargas et al., 2009). To test this hypothesis,
we investigated the importance of piRNA-related proteins
on viral infection. Re-analysis of previous deep-sequencing
data from mosquito-borne Semliki Forest virus (SFV)
(Togaviridae, Alphavirus) infection of U4.4 (derived from
Ae. albopictus) or Aag2 (derived from Ae. aegypti) cells (Siu
et al., 2011) revealed the presence of piRNA-like small
RNAs mapping mainly to a section of the SFV genome,
which decreased in Aag2 cells following knockdown for all
piRNA/Ago 3 proteins. Silencing of PIWI 4 protein
increased SFV replication and production but did not
decrease the presence of SFV-specific piRNA-like mole-
cules, confirming that the piRNA pathway does indeed
display antiviral activity and that piRNA 4 possibly acts as
an antiviral effector protein in this pathway.
RESULTS
SFV-specific piRNA-like molecules in aedine cell
lines
To determine whether the piRNA pathway specifically
targets SFV in mosquito cells, we first investigated if these
cells produce viral-specific piRNA-like molecules following
infection. We re-analysed data previously obtained from
deep sequencing of Aag2 and U4.4 cells infected with SFV
[RNA isolation 24 h post-infection (p.i.)]; deep sequencing
by using the Illumina Solexa platform as described in
Methods (Siu et al., 2011) and this time also mapped small
RNAs greater than 26 nt in length to the SFV genome. As
previously reported, the major species of virus-specific
small RNA molecules were viRNAs 21 nt in length (Siu
et al., 2011); however, small RNAs mapping to SFV in the
range of 25–29 nt could be observed for both cell lines (Fig.
1a). Most of these small RNA molecules mapped to the
sense orientation of the SFV in the 59 end of the
subgenomic RNA and had a bias for A at position 10, a
characteristic of secondary piRNAs (Fig. 1b and c). Besides,
the 59 ends of these complementary SFV-specific RNAs
were most frequently separated by 10 nt, a feature of
piRNAs produced by the ping-pong mechanism (Fig. 1d)
This is consistent with what has previously been reported
for SINV, CHIKV and SBV-specific piRNA-like RNAs
(Morazzani et al., 2012; Schnettler et al., 2013; Vodovar
et al., 2012). Having demonstrated the production of
piRNA-like RNAs in our mosquito cell infection systems,
we proceeded to investigate piRNA pathway functionality
by determining the effect of piRNA/Ago 3 silencing on SFV
replication.
Expression and knockdown of PIWI transcripts in
Aag2 cells
Given the lack of genomic information for Ae. albopictus,
these experiments were performed in Ae. aegypti-derived
Aag2 cells. To produce dsRNA molecules specifically
targeting single PIWIs or Ago 3, primers were designed
to amplify unique regions of these genes by RT-PCR. Ago 2
depletion was taken as a positive control as it has been
previously reported to be involved in the antiviral siRNA
pathway (Campbell et al., 2008b; Sa´nchez-Vargas et al.,
2009; van Rij et al., 2006), and Ago 1 was a negative control
that is known to be involved in the microRNA pathway.
Antiviral activity of the piRNA pathway
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Fig. 1. Aag2 and U4.4 cells produce both viRNAs and piRNA-like RNAs following SFV infection. (a) Size distribution of small
RNA molecules mapping to the SFV genome or anti-genome in Ae. aegypti (Aag2) or Ae. albopictus (U4.4); RNA was isolated
at 24 h p.i. Red and green indicate small RNAs mapping to the genome and anti-genome, respectively. (b) Relative nt frequency
and conservation per position of 25–29 nt small RNAs mapping to the genome and anti-genome of SFV in Aag2 and U4.4 cells
are indicated. Sequence is represented as DNA. The overall height of the nt represents sequence conservation. (c) Frequency
distribution of 28 nt small RNA molecules to the SFV genome or anti-genome in Aag2 and U4.4. The y-axis shows the
frequency of the 28 nt small RNAs mapping to the corresponding nt position of the x-axis (SFV genome length). Positive
numbers represent the frequency of small RNAs mapping to the genome and negative numbers those mapping to the anti-
genome. (d) Frequency map of 24–30 nt small RNAs mapping to the opposite strand of SFV4. Probabilities of
complementarities of the sense and antisense SFV-specific small RNAs were mapped along the small RNAs (position 0
represents the first nt).
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First, the primers were tested for their specificity to amplify
unique regions of the piRNA/Ago 3 mRNAs. As previously
reported (Vodovar et al., 2012), we amplified piRNA 4, 5, 6
and 7, as well as Ago 3. piRNAs 1–3 are highly
homologous, making unique primer design difficult.
Primers amplifying parts shared by either piRNAs 1, 2
and 3 or only 2 and 3 were successful, as well as piRNA 2
and 3 alone; however, attempts to amplify a unique region
of piRNA 1 were unsuccessful (Fig. 2a). Sequencing of the
PCR products confirmed their origin. Before, silencing the
piRNAs and Ago 3 with the dsRNA produced by in vitro
transcription, transfection efficiency of dsRNA in Aag2 was
assessed and optimized using internally labelled fluorescent
dsRNA molecules. A maximum of 28.6% positive cells was
observed (Fig. S1a, available in JGV Online). Cells were
transfectedwith100 ngdsRNA, eitherpiRNAspecific (1/2/3, 2/
3, 2, 3, 4, 5, 6, 7 and Ago 3) or control (eGFP specific), at 24 h
post-seeding using Lipofectamine 2000. Silencing of target
transcripts was determined by semi-quantitative reverse
transcriptase PCR (RT-PCR) 24 h post-transfection (p.t.),
and several experiments were quantified in relation to control
dsRNA using actin as a loading control (Fig. 2c). Aag2 cells
treated with dsRNA specific for piRNAs 1/2/3, 2/3, 4, 5, 6 and
Ago 3 showed a 10–42% reduction in target transcripts
compared to controls treatedwith eGFPdsRNA. Similar results
were observed for piRNAs 2, 3 and 7 (Fig. 2b, c). A cell viability
assay (cellTiter-Glo, Promega) was performed on all dsRNA-
treated cells to determine whether transcript knockdown had
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Fig. 2. Expression and knockdown of piRNA-related transcripts in Aag2 cells. (a) Detection of piRNA (1/2/3, 2/3, 2, 3, 4, 5, 6,
7) and Ago 3 transcripts in Ae. aegypti-derived Aag2 cells by RT-PCR using oligo-dT primers for reverse transcription, and
gene-specific primers for PCR. no RT represents the PCR product derived from samples lacking the superscript III enzyme. (b)
dsRNA-based silencing of piRNA (1/2/3, 2/3, 2, 3, 4, 5, 6 and 7), Ago 3, Ago 1 and Ago 2 transcripts or cells transfected with
eGFP-specific control dsRNA (ctrl) were detected in Aag2 cells by RT-PCR using gene-specific primers. Actin PCR product
was used as a control. (c) Quantification of mRNA knockdowns using ImageJ software (National Institutes of Health). Graph
shows the mean expression of five repeats normalized to actin expression and relative to eGFP-dsRNA controls. Error bars
show standard errors of means.
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an effect on cell viability, but no deleterious effect was observed
(data not shown).
Effect of piRNA/Ago 3 knockdown on SFV
replication
Next, the effect of piRNA/Ago 3 silencing on SFV replication
was investigated and compared to the knockdowns of Ago 1
and 2. dsRNA transfections inAag2 cellswere repeated, and at
24 h p.t., these cellswere infectedwith the reporter alphavirus
SFV4(3H)-RLuc [expressing Renilla luciferase (RLuc) as a
replicationmarker] (Fig. 3a). Infections were performed at an
m.o.i. of 0.1 (Fig. 3b, c), and RLuc activity was determined
48 h p.i. Significantly higher luciferase activity was detected
in cells treated with piRNA 4-specific dsRNA compared
to control (Fig. 3b, c). Cells treated with piRNA 6-, piRNA
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Fig. 3. piRNA/Ago 3 proteins inhibit SFV replication in Aag2 cells. (a) Schematic representation of SFV4 encoding Renilla
luciferase (RLuc) as reporter (flanked by duplicated nsP2-protease cleavage sites at the nsP3/4 junction) as part of the viral
non-structural polyprotein; SFV4(3H)-RLuc virus. (b) Aag2 cells transfected with dsRNA against piRNAs (1/2/3, 2/3, 4, 5 and
6), Ago 3 or eGFP-specific dsRNA (control) were infected with SFV4(3H)-RLuc 24 h p.t. at an m.o.i. of 0.1. The mean of four
independent experiments performed in triplicate are shown with standard errors (* represents p,0.05, t-test). (c) As (b) with
dsRNA specific against PIWIs (2, 3, 4 and 7), Ago 2, Ago 1 or eGFP-specific dsRNA (control). Luciferase activity was
measured 48 h p.i., and the means with standard errors are shown for three independent experiments performed in triplicate (*
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experiments performed in triplicate are shown with standard errors (* represents p,0.05, t-test).
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2/3- and piRNA 1/2/3-specific dsRNA showed an increase in
RLuc activity, although piRNA 4-specific dsRNA had a
stronger effect (Fig. 3b). Knockdown of Ago 1 had no effect
on luciferase expression compared to Ago 2 knockdowns,
which exhibited the highest increase in luciferase activity (Fig.
3c). In addition, plaque assays performed with supernatant
from dsRNA-transfected (eGFP, piRNA 4, Ago 1 and Ago 2)
and SFV4(3H)-RLuc-infected cells (m.o.i. of 0.1) showed
higher virus titre in cells treated with PIWI 4 or Ago 2 dsRNA
(Fig. 3d). To ensure that the observed increase of RLuc
activity in cells transfected with piRNA 4-specific dsRNAwas
not due to off-target effects of the dsRNA, experiments were
repeated with two additional piRNA 4-specific dsRNA
molecules (piRNA 4-2 and PIWI 4-3), resulting in similar
RLuc activity (Fig. S1b). Overall, these results show that
silencing Ago 2 and some piRNAs, in particular piRNA 4, in
Aag2 cells enhances SFV replication and virion production.
Effect of PIWI/Ago 3 knockdown on the
production of SFV-specific piRNA-like molecules
Deep-sequencing experiments were performed to deter-
mine in more detail if piRNA 4 is needed for the
production of SFV-specific piRNA-like molecules or rather
acts as an effector molecule using the produced SFV-
specific piRNA-like molecules to target the viral RNAs.
Knockdown of all piRNA/Ago 3 proteins was performed to
determined that any of these proteins are needed for the
production of SFV-specific piRNA-like molecules. First, we
established that the same cells could be targeted by dsRNA
transfection and SFV infection using internally labelled
fluorescent dsRNA and immunostaining for SFV nsP3 (Fig.
S1a). Next, cells were transfected either with a combination
of dsRNA molecules (targeting piRNA 1-3, 4, 5, 6, 7 and
Ago 3) or piRNA 4-specific dsRNA alone, followed by
SFV4 infection at an m.o.i. of 10. Cells transfected with
eGFP-specific dsRNA were used as control. At 24 h p.i.,
total RNA was isolated, small RNAs were sequenced and
the frequencies and SFV genome location of small RNAs
were determined. All samples showed the presence of 21 nt
SFV-specific small RNAs with a similar frequency to the
genome and anti-genome; however, their frequency differs
depending on the transfected dsRNAs, giving the highest
number in cells transfected with a combination of piRNA/
Ago 3-specific dsRNA, followed by piRNA 4-specific
dsRNA, with control eGFP-specific dsRNA giving the
lowest frequency. In addition, SFV-specific small RNAs of
length 26–30 nt with a peak at 27 nt, mapping mainly to
the sense orientation, could be observed in cells transfected
with eGFP-specific control dsRNA and piRNA 4-specific
dsRNA. Similar molecules were also present in cells
transfected with a combination of piRNA/Ago 3-specific
dsRNA but at a much lower frequency. These molecules
have all the piRNA-specific features described for the
previously identified SFV-specific small RNA molecules:
characterized by an A10 bias in the sense molecules, a U1
bias in the antisense molecules (Fig. 4a, b) and separation
of 10 nt of the 59ends of the complementary small RNAs
(Fig. S2b). As already observed for the other SFV-specific
piRNA-like molecules, they mainly map to the 59 end of
the subgenomic RNA (Fig. 2a). To further characterize the
response of SFV replication in these knockdown cells, the
experiments were repeated following infection with the
SFV4(3H)-RLuc reporter virus. Cells transfected with a
combination of piRNA/Ago 3-specific dsRNA molecules,
lacking piRNA 4 dsRNA, were also included. Increase in
RLuc activity compared to control cells could be observed
for all knockdowns; however, the strongest increase was
present in cells with piRNA 4 knockdown followed by
knockdown of all piRNAs/Ago 3. Interestingly, cells
transfected with a combination of piRNAs/Ago 3-specific
dsRNA but lacking PIWI 4-specific dsRNAs resulted in the
lowest RLuc increase (Fig. 4c). Overall, these results
support the involvement of piRNAs/Ago 3 for the
production of the SFV-specific piRNA-like molecules and
suggest that piRNA 4 acts as an effector protein that targets
the virus but is not needed for the production of SFV-
specific piRNA-like molecules.
Can dsRNA molecules induce piRNA production
Knockdown experiments of Ago 3 performed in Anopheles
gambiae suggests that at least some of the PIWI pathway
proteins are also involved in the exogenous dsRNA-
induced silencing response (Hoa et al., 2003). In addition,
recent experiments in aedine mosquitoes infected with
transgenic CHIKV expressing the dsRNA-binding protein
B2 suggest that dsRNA molecules are an inducer of the
piRNA pathway (Morazzani et al., 2012), as is known for
the exogenous siRNA pathway. To investigate if dsRNA on
its own can be processed into piRNA-like molecules, we
transfected Aag2 or U4.4 cells with dsRNA molecules
derived from the eGFP sequence. Subsequently, RNA was
isolated 24 h p.t., followed by sequencing and mapping of
small RNAs to the eGFP target sequence as described
above. As expected, small RNAs of 21 nt in size that
mapped to the sense or antisense orientation and along the
eGFP sequence were observed as the majority, indicating
induction of the exogenous RNAi pathway (Fig. 5a, b).
Some small RNAs in the 25–29 nt range mapping to the
eGFP input sequence were identified; however, no specific
sequence logo identifying them as piRNA-like molecules
was detected (data not shown). This suggests that ssRNA
(for example from virus replication) is needed for the
production of piRNA molecules but does not rule out a
link between the siRNA and piRNA pathways.
DISCUSSION
Until now, antiviral RNA silencing activities in mosquitoes
have mainly been reported for the exogenous siRNA
pathway. The identification of piRNA-like virus-specific
RNA molecules in drosophila OSS (Wu et al., 2010),
mosquitoes and mosquito-derived cells against different
arboviruses suggested a contribution of the piRNA
Antiviral activity of the piRNA pathway
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pathway in the antiviral response (Hess et al., 2011; Le´ger
et al., 2012; Morazzani et al., 2012; Schnettler et al., 2013;
Scott et al., 2010; Vodovar et al., 2012). However, this role
has not been experimentally proven. The piRNA pathway is
known to target transposons and thereby ensures genome
stability, especially in germline cells. As some arboviruses
have been reported to be vertically transmitted (Anderson
et al., 2012; Mulyatno et al., 2012), an antiviral response by
the piRNA pathway in germline cells may constitute an
antiviral mechanism to inhibit vertical transmission or
limit virus replication in developing embryos. On the other
hand, a putative piRNA pathway in somatic tissues could
add another layer to small RNA-based antiviral responses
controlling arboviral infection. The finding that SFV-
produced piRNA-like small RNA molecules in Ae. aegypti-
and Ae. albopictus-derived cell lines is in accordance with
recently published work showing similar results for
CHIKV, SINV, LACV and SBV (Morazzani et al., 2012;
Schnettler et al., 2013; Vodovar et al., 2012). The
observation that the knockdown of some PIWI proteins
in Aag2 cells has a positive effect on SFV infection supports
the hypothesis that the piRNA pathway and possibly the
viral-specific piRNA-like small RNAs have an antiviral
function in these cells. A similar result has been previously
reported in anopheline mosquitoes. Indeed, A. gambiae
showed an increase in O’nyong-nyong virus (Togaviridae;
Alphavirus) following Ago 3 knockdown (Keene et al.,
2004). We extend this finding to aedine mosquitoes and
highlight the additional contribution of piRNA 4. The fact
that virus-specific piRNA-like small RNA molecules are
not specific to Ae. aegypti but can also be found in infected
Ae. albopictus, coupled with the expression of all piRNA
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Fig. 4. piRNA/Ago 3 proteins are involved in the production of SFV-specific piRNA-like molecules in Aag2 cells. (a) Size
distribution of small RNA molecules mapping to the SFV genome or anti-genome in Aag2 transfected with eGFP-specific
control dsRNA, a combination of Piwi/Ago 3 dsRNA (Piwi 1/2/3, 2/3, 2, 3, 4, 5, 6, 7 and Ago 3) or Piwi 4-specific dsRNA,
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and anti-genome of SFV in Aag2 prior to transfection with the above-mentioned dsRNA molecules. Sequence is represented as
DNA. The overall height of the nucleotide represents sequence conservation. (c) Aag2 cells transfected with different
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experiments performed in triplicate are shown with standard errors (* represents p,0.05, t-test).
E. Schnettler and others
1686 Journal of General Virology 94
pathway proteins (PIWIs and Ago 3) in somatic tissues (head
and thorax) (Morazzani et al., 2012), indicates that the
‘antiviral’ piRNA pathway is probably not specific to Ae.
aegypti but could possibly be present in Ae. albopictus as well.
It is not known if the same is true for drosophila. Viral-
specific piRNAs have been described in drosophila OSS (Wu
et al., 2010), but it is not known if they have any antiviral
activity in these cells. In addition, no viral-specific piRNAs
have been reported in somatic tissue or derived cells of
drosophila until now, which is in contrast to aedine
mosquitoes and their derived cells (Hess et al., 2011; Le´ger
et al., 2012; Morazzani et al., 2012; Schnettler et al., 2013;
Vodovar et al., 2012). This could be due to the differences in
PIWI pathway protein expression between drosophila and
Ae. aegypti (Campbell et al., 2008a). However, knockdown of
piRNA in drosophila results in increased WNV production
similar to that observed in Ago 2 knockdowns (Chotkowski
et al., 2008), which would also support an antiviral activity of
the piRNA-related pathway in drosophila. More research is
needed to determine the possible antiviral activity of piRNAs
in drosophila and whether this is restricted to ovary cells or is
found in all somatic tissue, and to determine the precise
differences between these pathways in aedinemosquitoes and
drosophila.
We do not know how the antiviral piRNA pathway is
induced in aedine mosquitoes, although previous observa-
tions have suggested a dsRNA molecule as the inducer
(Morazzani et al., 2012). This would suggest crosstalk
between the siRNA and piRNA pathways. A similar result
has been reported for A. gambiae-derived cells, which show a
decrease in dsRNA-induced reporter gene expression fol-
lowing Ago 3 knockdown (Hoa et al., 2003), indicating such
crosstalk even in non-aedine mosquitoes. However, the lack
of piRNA-like molecules produced in the case of dsRNA
transfection alone (Fig. 5) suggests the need for ssRNA (active
viral replication) to induce piRNA production. The inhib-
itory effect observed by the expression of the dsRNA-binding
RNAi suppressor B2 by CHIKV on the production of viral-
specific piRNAs suggests that this is a secondary effect as
dsRNAs are replication intermediates required for ssRNA
production (Morazzani et al., 2012). The observation that
most piRNAsmap to the coding strand region of the 59 end of
the SFV subgenomic mRNA, SINV or CHIKV (Morazzani
et al., 2012; Vodovar et al., 2012) suggests that perhaps
particular transcripts or genome regions are preferentially
targeted. In this case, viral-specific dsRNA, either due to the
sequence or structural features such as dsRNA, could be the
inducer of the piRNA pathway. Characterization of the viral-
specific piRNA-like molecules suggests a ping-pong produc-
tion mechanism; however, knockdown of Ago 3, which is
known to be important for the ping-pong mechanism in
drosophila, did not result in an increase of SFV replication. It
could be possible that the observed viral-specific piRNA-like
molecules are produced in an Ago 3 independent manner in
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Ae. aegypti in contrast to drosophila, or that the obtained
knockdown of Ago 3 was not sufficient.
To date, it is not definitively known if the viral-specific
piRNA-like molecules in mosquitoes and derived cell lines
are really produced through the piRNA pathway using
PIWI and Ago 3 proteins, although their ping-pong
signature highly suggests this production pathway. In
addition, piRNA production models were shown in
drosophila using at least two PIWI family proteins for
the production of primary and secondary piRNA mol-
ecules, but knockdown experiments only showed a strong
effect on SFV production for Piwi 4. The low frequency of
SFV-specific piRNA-like molecules found in cells with
knockdown of all piRNA and Ago 3 proteins strongly
supports their involvement in the production of these
molecules. However, the lack of decrease in SFV-specific
piRNA-like molecules in piRNA 4 knockdowns and the
increase in SFV replication and production suggest an
effector role of this PIWI-clade Ago protein by using the
SFV-specific piRNA-like molecules to target the virus. The
observed increase in SFV replication in both piRNA 4 and
all PIWI/Ago3 knockdown cells compared to control
dsRNA could also explain the increase of 21 nt viRNAs
in these cells. In addition, the increase in SFV-specific
piRNA-like molecules in combination with a higher SFV
replication again suggests that piRNA 4 is not needed for
SFV-specific piRNA-like production, but rather it is used
to target and thereby silence the virus.
Together, these results show that arbovirus replication is
able to trigger the piRNA pathway and that silencing of
piRNA-related proteins reduces viral-specific piRNA-like
molecules and enhances viral replication and production,
suggesting an antiviral response by the piRNA pathway.
Both the piRNA and exogenous siRNA pathways may act in
combination to control viral infections in mosquito cells.
Future research is needed to determine the viral inducer
molecule of the piRNA pathway andmap the involvement of
each piRNA/Ago 3 protein in detail. We cannot exclude that
some PIWI-clade proteins that are important in viral
piRNA-like production have been missed due to either
inefficient knockdown or the need of combinational
knockdowns, but our results already suggest piRNA 4 as
an effector protein. Besides, the proposed linkage between
the siRNA and piRNA pathways has yet to be investigated,
and it is not yet known if the piRNA and siRNA pathways
are restricting different parts of the viral infection (acute
versus persistent infection) in mosquitoes. Experiments in
the exogenous RNAi pathway knockout cell lines, such as
C6/36 (Brackney et al., 2010; Scott et al., 2010), suggest that
the piRNA pathway may still be able to control viral
infection to some extent on its own; however, further studies
are required to fully assess interaction between the pathways.
METHODS
Cells, plasmids and virus. Ae. albopictus-derived U4.4 and Ae.
aegypti-derived Aag2 cells were maintained in L-15 medium
supplemented with 10% FCS and 10% tryptose phosphate broth at
28 uC. Amplification and titration of SFV (strain SFV4) and the
SFV4(3H)-RLuc reporter virus and infection of U4.4 and Aag2 cells
were performed in a similar way as previously described; infections
were performed at growth temperature (28 uC) (Siu et al., 2011).
Briefly, viruses were grown in BHK-21 cells in Glasgow minimum
essential medium (GMEM) with 5% FCS and 10% tryptose
phosphate broth at 37 uC with 5% CO2. Virus purified from the
supernatant or virus present in supernatant was titrated by plaque
assay on BHK-21 cells using an Avicell (0.6%)/MEM overlay with 2%
FCS. Infection of mosquito cells was performed in L-15 medium with
10% FCS and 10% tryptose phosphate broth for 1 h at 28 uC,
followed by a washing step with PBS and overlay with media.
Reverse transcription and PCR. RT-PCR was performed with total
RNA (500 ng) isolated using TRIzol (Invitrogen), Superscript III and
oligo-dT primer, according to the manufacturer’s protocol. piRNA/
Ago 3 transcripts were detected and amplified by PCR (2 ml of the
cDNA reaction) using primers containing T7 RNA polymerase
promoter sequences (Table S1). For the detection of the transcripts,
40 rounds of PCR using KOD polymerase were performed in contrast
to 35 rounds for semi-quantitative PCR using GoTaq polymerase. The
eGFP-derived PCR product was produced by using eGFP-C1
(Clontech) as a template. PCR products were gel-purified and used
for dsRNA production or first cloned into the pJet blunt 1.2 vector
(Fermentas) and sequenced.
In vitro dsRNA transcription. dsRNA molecules for PIWI/Ago 3
and eGFP were produced with a T7 RNA polymerase in vitro
transcription kit (Megascript RNAi kit, Ambion) using a PCR
product as a template, followed by column purification. Internally
fluorescently labelled eGFP-specific dsRNA was produced in the same
way but using fluorescein-labelled rNTP mix (Roche) following the
manufacturer’s protocol, and purified by ethanol precipitation.
Primer sequences are indicated in Table S1.
Cell viability assay. Viability of cells transfected with dsRNAmolecules
was determined using a CellTiter-Glo luminescent cell viability assay
(Promega) following the manufacturer’s recommendations.
Luciferase assay. Luciferase activities were determined using a Dual
Luciferase assay kit (Promega) on a GloMax luminometer following
cell lysis in Passive Lysis Buffer.
Transfection. Aag2 cells (1.76105 per well) were seeded in 24-well
plates, 24 h before transfection. PIWI/Ago 3 transcripts were silenced
by the transfection of 100 ng dsRNA per well (PIWI specific or 400 nt
eGFP) at 24 h post-seeding with Lipofectamine 2000 (Invitrogen),
following the manufacturer’s protocol. At 24 h p.t., cells were either
harvested to isolate RNA for RT-PCR or infected with SFV4(3H)-
RLuc at the indicated m.o.i. Supernatant from infected cells (m.o.i. of
0.1) was used to determine virus titre by plaque assays on BHK-21
cells. In addition, luciferase expression was measured 48 h p.i. as
described above.
Small RNA isolation and sequencing. Small RNA sequencing was
carried out by ARK-Genomics (The Roslin Institute, University of
Edinburgh) and The GenePool (University of Edinburgh) using the
Illumina Solexa platform. Approximately 56105 U4.4 cells and
66105 Aag2 cells per well were transfected in a 6-well plate with 1 mg
eGFP-derived dsRNA (720 nt) or left untreated.
For the infection experiments, Aag2 cells were transfected with 1 mg
piRNA 4 or eGFP dsRNA or 200 ng each piRNA1-3, 4, 5, 6, 7 and
Ago 3 dsRNA using Lipofectamine 2000. At 24 h p.t., cells were
infected with SFV4 at an m.o.i. of 10. At 24 h p.t. or p.i., RNA was
isolated using 1 ml TRIzol (Invitrogen) per well, followed by
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purification, sequencing and analysis as previously described
(Schnettler et al., 2013).
Immunostaining. Aag2 cells were fixed in formaldehyde and
permeabilized by 0.3% Triton/PBS for 30 min, followed by a wash
with PBS. Cells were pre-incubated with CAS-Block for 1 h at room
temperature, followed by incubation with CAS-Block diluted SFV
nsP3-specific antibody (1 : 500) (Siu et al., 2011) for 90 min at room
temperature. After three washing steps with PBS, an anti-rabbit
antibody conjugated with Alexa Fluor 543 diluted in CAS-Block
(1 : 1000) was incubated for 60 min at room temperature. Following
further washing steps with PBS, cells were dried and mounted with
DAPI-containing hard set Vectashield mounting medium (Vector
Laboratories), and fluorescence was detected on a Zeiss LSM Meta
microscope.
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